Patent: 9,533,044
✉ Email this page to a colleague
Summary for Patent: 9,533,044
Title: | Methods of treating inflammatory disorders using high concentration natalizumab compositions |
Abstract: | Formulations of VLA-4 binding antibody are described. |
Inventor(s): | Maloney; Kevin (Nashua, NH) |
Assignee: | BIOGEN MA INC. (Cambridge, MA) |
Application Number: | 13/530,879 |
Patent Claims: | see list of patent claims |
Details for Patent 9,533,044
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 11/23/2004 | ⤷ Try a Trial | 2027-06-14 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |